Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A
Graphical abstract
Pyrazolopyrimidines were discovered as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A. In addition to its intrinsic activity, compound 9n significantly enhances nicotinic acid binding to the receptor, thereby potentiating the functional efficacy of nicotinic acid.
References and notes (19)
N. Engl. J. Med.
(1999)- et al.
Curr. Opin. Pharmacol.
(2006)et al.Drug Discov. Today: Disea. Mech.
(2006) - (a)Boatman, D. P.; Schrader, T. O.; Semple, G.; Skinner, P. J.; Jung, J.-K. Patent WO 2006/069242...(b)Semple, G.; Schrader, T.; Skinner, P. J.; Colletti, S. L.; Gharbaoui, T.; Imbriglio, J. E.; Jung, J.-K.; Liang, R.;... et al.
Bioorg. Med. Chem. Lett.
(2007) - Cao, G.; Xue, C.-B.; Anand, R.; Huang, T.; Kong, L.; Glenn, J.; Feng, H. Patent WO 2007/015744...
- et al.
J. Biol. Chem.
(2005) - et al.
J. Heterocycl. Chem.
(1995) - et al.
Stroke
(1993)et al.Br. Med. J.
(1984) - et al.
J. Am. Coll. Cardiol.
(1986)Crit. Rev. Clin. Lab. Sci.
(1998)et al.Circulation
(2004) - et al.
Eur. J. Immunol.
(2001)
Cited by (23)
Resourceful synthesis of pyrazolo[1,5-a]pyrimidines under ultrasound irradiation
2013, Ultrasonics SonochemistryCitation Excerpt :Pyrazolo[1,5-a]pyrimidines are of considerable chemical and pharmacological importance, since they have shown COX-2 selective inhibition [9] and KDR kinase inhibition [10]. More recently, pyrazolo[1,5-a]pyrimidine was described as the first class of allosteric agonists for the nicotinic acid receptor GPR109A [11,12]. Also, the number of patents for pyrazolo[1,5-a]pyrimidines with pharmacological activity has increased drastically [13,14].
Biological and Pharmacological Roles of HCA Receptors
2011, Advances in PharmacologyCitation Excerpt :Nevertheless, submicromolar affinity and potency were observed in this series, although the compounds behaved poorly in pharmacokinetic studies. Shen et al. (2008) described another series of agonists for the HCA2 receptor with intriguing pharmacological activity, in particular, 10 in Fig. 3. When tested alone, it behaved as a partial agonist with eightfold higher potency than nicotinic acid.
Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity
2010, Bioorganic and Medicinal Chemistry Letters